One of the world's largest centers for clinical trials with mice, featuring advanced translational oncology platforms with fully annotated collections of patient-derived tumor graft models, will be established in Jiangsu province.

Shanghai Institute of Materia Medica under the Chinese Academy of Sciences and the Crown Bioscience, a US-based oncology service company, has recently reached an agreement to form a strategic partnership focusing on translational oncology and to join forces to build the center in Taicang, Jiangsu province.

In addition to combining the existing nearly 1,000 model collections, the center will build several thousand more new models focusing on cancers affecting Asians, including liver, lung, gastric and colorectal cancers.